COVID-19 -- United Kingdom
Late Monday [22 Mar 2021], the Data and Safety Monitoring Board (DSMB) notified NIAID, BARDA [Biomedical Advanced Research and Development Authority], and AstraZeneca that it was concerned by information released by AstraZeneca on initial data from its COVID-19 vaccine clinical trial.
The DSMB expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data.
We urge the company to work with the DSMB
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?8263780&promed&0
No comments:
Post a Comment